BioElectronics bags second place in the medical device category of the 2009 Wall Street Journal Innovation Award

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has been selected as a runner up in the medical device category of the 2009 Wall Street Journal Innovation Awards unveiled in today's global editions and online. The award was given for the Company's wearable patch that uses pulsed electromagnetic energy to deliver drug-free pain relief for a variety of conditions.

Richard Staelin, Chairman of the Board of BioElectronics, said, "We are gratified that such a prestigious organization has validated the work of BioElectronics management to bring our innovative technology to market. For a start-up of our size, it is exciting to be on a winners list that includes this year established technology leaders like Abbot Labs, HP, Qualcomm, National Semiconductor, Intel and NASA. The Wall Street Journal said that they received almost 500 nominations from around the world and selected only 36 winners." A complete file of this year's winners is available on the WSJ Online website or on http://www.healfasttherapy.com/wsjinnovationaward.

Andrew Whelan, BioElectronics CEO, will accept the award at The Wall Street Journal's 2009 Technology Innovation Awards ceremony on Oct. 13 at a dinner in Redwood City, Calif. featuring a keynote address by Marc Benioff, chairman and chief executive of Salesforce.com Inc. The ceremony will be held in conjunction with the Dow Jones VentureWire Technology Showcase.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered MRI predicts outcomes in prostate cancer